Evidence map›Paper›PMID 29176665›Full record

ArticleNature communications2017

Microbial volatile communication in human organotypic lung models.

Layla J Barkal, Clare L Procknow, Yasmín R Álvarez-García, Mengyao Niu, José A Jiménez-Torres, Rebecca A Brockman-Schneider, James E Gern, Loren C Denlinger, Ashleigh B Theberge, Nancy P Keller and 2 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 101 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Homeostasis of Gut Microbiota Protects against Susceptibility to Fungal Pneumonia.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Advancements in preclinical human-relevant modeling of pulmonary vasculature on-chip.European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences · 2024
    Review
  13. Article
  14. Review
  15. Eosinophil-Epithelial Cell Interactions in Asthma.International archives of allergy and immunology · 2024
    Review
  16. Review
  17. Volatilomes of human infection.Analytical and bioanalytical chemistry · 2024
    Review
  18. On the path to predicting immune responses in the lung: Modeling the pulmonary innate immune system at the air-liquid interface (ALI).European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences · 2023
    Review
  19. Innovative three-dimensional models for understanding mechanisms underlying lung diseases: powerful tools for translational research.European respiratory review : an official journal of the European Respiratory Society · 2023
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Layla J BarkalDepartment of Biomedical Engineering, University of Wisconsin-Madison, Madison, WI, 53706, USA.ORCID http://orcid.org/0000-0002-4734-7197
Clare L ProcknowDepartment of Bacteriology, University of Wisconsin-Madison, Madison, WI, 53706, USA.
Yasmín R Álvarez-GarcíaDepartment of Chemistry, University of Wisconsin-Madison, Madison, WI, 53706, USA.
Mengyao NiuDepartment of Medical Microbiology and Immunology, University of Wisconsin-Madison, Madison, WI, 53706, USA.
José A Jiménez-TorresDepartment of Biomedical Engineering, University of Wisconsin-Madison, Madison, WI, 53706, USA.
Rebecca A Brockman-SchneiderDepartment of Pediatrics, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, 53705, USA.
James E GernDepartment of Pediatrics, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, 53705, USA.
Loren C DenlingerDepartment of Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, 53705, USA.
Ashleigh B ThebergeDepartment of Chemistry, University of Washington, Seattle, WA, 98195, USA.
Nancy P KellerDepartment of Bacteriology, University of Wisconsin-Madison, Madison, WI, 53706, USA.ORCID http://orcid.org/0000-0002-4386-9473
Erwin BerthierDepartment of Chemistry, University of Washington, Seattle, WA, 98195, USA. erwin.berthier@gmail.com.
David J BeebeDepartment of Biomedical Engineering, University of Wisconsin-Madison, Madison, WI, 53706, USA. djbeebe@wisc.edu.
University of Wisconsin–Madison · USUniversity of Washington · US

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI AMY TRENTHAM-DIETZ · 1985 to 2026
$142.6M
Virus-Bacterial Interactions and Exacerba of AsthmaP01HL070831 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI OBER, CAROLE · 2002 to 2017
$31.3M
Research Training for Computation and Informatics in Biology and MedicineT15LM007359 · NLM · UNIVERSITY OF WISCONSIN-MADISON · PI Mark W. Craven, Colin Noel Dewey · 2002 to 2026
$22.6M
Wisconsin Infant Study Cohort (WISC)U19AI104317 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI Irene M Ong · 2013 to 2026
$22.5M
INTEGRATED TRAINING FOR PHYSICIAN-SCIENTISTST32GM008692 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI BURKARD, MARK E · 1998 to 2020
$10.3M
Wisconsin Multidisciplinary K12 Urologic Research Career Development ProgramK12DK100022 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI CHAD M. VEZINA · 2013 to 2026
$8.6M
RESEARCH TRAINING IN HEMATOLOGYT32HL007899 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI Jane Ellen Churpek · 1998 to 2026
$8.2M
Mechanisms of an Aspergillus fumigatus virulence mutantR01AI065728 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI KELLER, NANCY P · 2006 to 2017
$3.6M
Nucleotide receptor modulation of airway eicosanoids during asthma exacerbationsR01HL115118 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI DENLINGER, LOREN C · 2013 to 2017
$2.4M
Understanding cell migration through microscale in vitro modelsR01EB010039 · NIBIB · UNIVERSITY OF WISCONSIN-MADISON · PI BEEBE, DAVID J, HUTTENLOCHER, ANNA · 2011 to 2014
$1.7M
Enabling NF-kB Signal Transduction Studies in Primary Multiple Myeloma CellsR01CA155192 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI BEEBE, DAVID J, MIYAMOTO, SHIGEKI · 2012 to 2016
$1.4M
NCI NIH HHS P30 CA014520NCI NIH HHS R01 CA155192NHLBI NIH HHS P01 HL070831NHLBI NIH HHS R01 HL115118NHLBI NIH HHS T32 HL007899NIAID NIH HHS R01 AI065728NIAID NIH HHS U19 AI104317NIBIB NIH HHS R01 EB010039NIDDK NIH HHS K12 DK100022NIGMS NIH HHS T32 GM008692NLM NIH HHS T15 LM007359
6 · The paper itself

Abstract

We inhale respiratory pathogens continuously, and the subsequent signaling events between host and microbe are complex, ultimately resulting in clearance of the microbe, stable colonization of the host, or active disease. Traditional in vitro methods are ill-equipped to study these critical events in the context of the lung microenvironment. Here we introduce a microscale organotypic model of the human bronchiole for studying pulmonary infection. By leveraging microscale techniques, the model is designed to approximate the structure of the human bronchiole, containing airway, vascular, and extracellular matrix compartments. To complement direct infection of the organotypic bronchiole, we present a clickable extension that facilitates volatile compound communication between microbial populations and the host model. Using Aspergillus fumigatus, a respiratory pathogen, we characterize the inflammatory response of the organotypic bronchiole to infection. Finally, we demonstrate multikingdom, volatile-mediated communication between the organotypic bronchiole and cultures of Aspergillus fumigatus and Pseudomonas aeruginosa.

Indexed as

AspergillosisAspergillus fumigatusBronchiolesCytokinesHost-Pathogen InteractionsHumansLung DiseasesModels, BiologicalPseudomonas aeruginosaPseudomonas InfectionsVolatile Organic CompoundsCytokinesVolatile Organic Compounds

Identifiers

PMID29176665
PMCPMC5701243
OpenAlexW2770346915

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.